Biomedical subjects
B S Chong
Publications and source records attributed to B S Chong.
The question is what is the best retrograde root filling material not whether we should move from amalgam.
Explore the source record for details and available documents.
A prospective clinical study of Mineral Trioxide Aggregate and IRM when used as root-end filling materials in endodontic surgery.
AIM: To assess the success rate of the root-end filling material, Mineral Trioxide Aggregate (MTA). METHODOLOGY: Referred adult patients were recruited using strict entry criteria and randomly allocated to receive MTA or IRM. A standardized surgical technique was employed: the root end was resected perpendicularly and a root-end cavity was prepared ultrasonically and filled. A radiograph taken immediately after surgery was compared with those taken at 12 and 24 months. Customised film holders and the paralleling technique were used; radiographs were assessed by two trained observers using agreed criteria. The results from 122 patients (58 in IRM group, 64 in MTA group) after 12 months and 108 patients (47 in IRM group, 61 in MTA group) for the 24-month review period were analysed using the chi2 test. RESULTS: The highest number of teeth with complete healing at both times was observed when MTA was used. When the numbers of teeth with complete and incomplete (scar) healing, and those with uncertain and unsatisfactory healing were combined, the success rate for MTA was higher (84% after 12 months, 92% after 24 months) compared with IRM (76% after 12 months, 87% after 24 months). However, statistical analysis showed no significant difference in success between materials (P > 0.05) at both 12 and 24 months. CONCLUSIONS: In this study, the use of MTA as a root-end filling material resulted in a high success rate that was not significantly better than that obtained using IRM.
Entacapone.
OBJECTIVE: To introduce entacapone, a new catechol-O-methyltransferase inhibitor, and discuss its pharmacology, pharmacodynamics, pharmacokinetics, clinical efficacy, drug interactions, adverse events, dosage guidelines, and therapeutic and formulary considerations. DATA SOURCE: A MEDLINE database search (1966-December 1999) was performed to identify relevant English-language articles including recent studies, abstracts, and reviews. Search terms included entacapone, OR-611, catechol-O-methyltransferase inhibitor, and Parkinson's disease. STUDY SELECTION: Relevant published human studies were chosen to summarize the pharmacokinetics, clinical efficacy, adverse effects, and drug interactions. DATA EXTRACTION: All available human clinical trials were reviewed. DATA SYNTHESIS: Entacapone is the second medication of a new class of drugs, the catechol-O-methyltransferase inhibitors, indicated for clinical use as an adjunct to levodopa/carbidopa to treat patients with idiopathic Parkinson's disease who experience the signs and symptoms of end-of-dose wearing-off. Entacapone in combination with levodopa/dopa decarboxylase inhibitor has been shown to increase the AUC of levodopa, which leads to less fluctuation of levodopa plasma concentrations. Clinically, the duration of motor response to levodopa was prolonged as reflected by an increase in the mean on time. The addition of entacapone resulted in a decrease in the mean daily dosage of levodopa. The recommended dosage of entacapone is 200 mg administered orally with each dose of levodopa/carbidopa, up to a maximum of eight doses per day. Common adverse effects include dyskinesia, nausea, diarrhea, and urine discoloration. CONCLUSIONS: Entacapone should be considered as add-on treatment to levodopa/carbidopa in Parkinson's disease patients with end-of-dose wearing-off effect.
Treatment options for rheumatoid arthritis: celecoxib, leflunomide, etanercept, and infliximab.
OBJECTIVE: To review new pharmacologic agents approved for use in the management of rheumatoid arthritis (RA). DATA SOURCES: A MEDLINE search (1966-January 2000) was conducted to identify English-language literature available on the pharmacotherapy of RA, focusing on celecoxib, leflunomide, etanercept, and infliximab. These articles, relevant abstracts, and data provided by the manufacturers were used to collect pertinent data. STUDY SELECTION: All controlled and uncontrolled trials were reviewed. DATA EXTRACTION: Agents were reviewed with regard to mechanism of action, efficacy, drug interactions, pharmacokinetics, dosing, precautions/contraindications, adverse effects, and cost. DATA SYNTHESIS: Traditional pharmacologic treatments for RA have been limited by toxicity, loss of efficacy, or both. Increasing discoveries into the mechanisms of inflammation in RA have led to the development of new agents in hopes of addressing these limitations. With the development of celecoxib, a selective cyclooxygenase-2 inhibitor, the potential exists to minimize the gastrotoxicity associated with nonsteroidal antiinflammatory drugs. Leflunomide has been shown to be equal to or less efficacious than methotrexate, and may be beneficial as a second-line disease-modifying antirheumatic drug (DMARD). The biologic response modifiers, etanercept and infliximab, are alternatives that have shown benefit alone or in combination with methotrexate. However, they should be reserved for patients who fail to respond to DMARD therapy. Further studies should be conducted to evaluate the long-term safety and efficacy of these agents as well as their role in combination therapy. CONCLUSIONS: Celecoxib, leflunomide, etanercept, and infliximab are the newest agents approved for RA. Clinical trials have shown that these agents are beneficial in the treatment of RA; however, long-term safety and efficacy data are lacking.
Radiopacity of resin-modified glass ionomer liners and bases.
STATEMENT OF PROBLEM: Lining and base materials for restorations have traditionally been autopolymerized and include conventional glass ionomer cements. Light-cured resin-modified glass ionomer cements have recently become available, but a lack of information exists regarding their radiopacity. PURPOSE OF STUDY: In this study the radiopacity of glass ionomer cements was assessed with a standard method that related densitometric measurements to an equivalent thickness of aluminum. MATERIAL AND METHODS: Radiographs were made of specimens with seven materials commonly used as liners and bases: two reinforced zinc oxide-eugenol cements (Kalzinol and Intermediate Restorative Material, De Trey Dentsply), a zinc phosphate cement (SS White, S.S. White Manufacturing), three resin-modified glass ionomer liners (Vitrebond [3M Dental Products], Fuji Lining LC [GC Dental], and Photac-Bond [ESPE Dental Medizin GmbH]), and a conventional glass ionomer liner/base (Ketac-Bond, ESPE Dental-Medizin GmbH), with dentin as a control. The radiopacity of all materials was compared with dentin. RESULTS: Kalzinol had the greatest radiopacity of the materials tested. The glass ionomer cements were substantially less radiopaque than other materials. The conventional glass ionomer cement, Ketac-Bond, was more radiopaque than the three resin-modified glass ionomer cements. Of the three resin-modified glass ionomer materials, Vitrebond was the most radiopaque and Fuji Lining LC was the least radiopaque. CONCLUSION: Future resin-modified glass ionomer materials are recommended to be formulated to increase radiopacity for improved clinical detection.
Short-term tissue response to potential root-end filling materials in infected root canals.
The short-term tissue responses to two potential root-end filling materials, a light-cured glass ionomer cement (Vitrebond) and a reinforced zinc oxide-eugenol cement (Kalzinol), were compared with that to amalgam using a previously devised experimental model. In 24 premolar teeth of beagle dogs (47 roots), a collection of endodontic pathogenic bacteria was first inoculated into the root canals to induce periradicular lesions. On each root, an apicoectomy was performed and root-end cavities prepared to receive fillings of each material. The teeth and surrounding jaw were removed after 2 weeks (23 roots) and 1 week (24 roots); they were then prepared for histological examination. The tissue response to amalgam fillings after 2 weeks and 1 week was marked by moderate or severe inflammation on all roots, and extended to < or = 0.5 mm or > 0.5 mm in 15 out of 16 roots. In contrast, after 2 weeks, the majority of roots filled with Kalzinol showed little or moderate inflammation, while the tissue response to Vitrebond was the best of the three materials, and was also the least extensive. After 1 week, the overall best tissue response was with Vitrebond, followed by Kalzinol. The differences between materials for both time periods with either none or few inflammatory cells when compared with that with either moderate or severe inflammation were not statistically significant (P < 0.02). However, the differences between materials for both time periods with no inflammation or inflammation extending < 0.2 mm when compared with that with inflammation extending > 0.2 mm (< or = 0.5 mm or > 0.5 mm) were statistically significant (P < 0.01). Apart from amalgam, in which healing was marked by the persistence of a localized focus of inflammation adjacent to the root-end filling, even though there were intersample variations, there was little overall difference in the temporal and qualitative healing response to Vitrebond and Kalzinol. Both Vitrebond and Kalzinol have potential as root-end filling materials, as the tissue response was considerably more favourable than that to amalgam even in the short-term.
Radiological assessment of the effects of potential root-end filling materials on healing after endodontic surgery.
The effects of three root-end filling materials on healing following endodontic surgery were assessed radiologically and correlated with histological findings reported elsewhere. The materials compared were a light-cured glass ionomer cement (Vitrebond), a reinforced zinc oxide-eugenol cement (Kalzinol) and amalgam. The root canals of 27 two-rooted mandibular premolar teeth of six beagle dogs were inoculated with endodontic pathogenic bacteria to induce periradicular lesions. The roots were apicected and root-end cavities filled with the tested filling materials. The teeth and surrounding jaw were removed after 4 weeks (30 roots) or 8 weeks (24 roots). Radiographs were taken of each jaw section and subjected to image analysis. Healing was evaluated based on measurements of the size of the periradicular radiolucent areas. ANOVA disclosed no statistically significant differences in the size of the periradicular areas either between time periods or between materials. These results did not correlate with the tissue responses in the same material as assessed histologically and previously reported. The use of radiographs alone to assess healing after endodontic surgery in the dog mandible is unsatisfactory, and should not be regarded as a substitute for histological examination for the determination of healing.
Tissue response to potential root-end filling materials in infected root canals.
The tissue responses to two potential root-end filling materials, a light-cured glass ionomer cement (Vitrebond) and a reinforced zinc oxide-eugenol cement (Kalzinol) were compared with that to amalgam. In 27 premolar teeth of beagle dogs (54 roots), a collection of endodontic pathogenic bacteria was first inoculated into the root canals to induce periapical lesions. On each root, an apicectomy was performed and root-end cavities prepared to receive fillings of each material. The teeth and surrounding jaw were removed after 8 weeks (24 roots) and 4 weeks (30 roots); and they were prepared for histological examination. The tissue response to amalgam fillings after 4 and 8 weeks was marked by moderate or severe inflammation on all roots, and extended > 0.5 mm in 10 out of 18 roots. In contrast, after 8 weeks, the majority of roots filled with Kalzinol showed little or moderate inflammation while the tissue response to Vitrebond was the best of the three materials, and was also less extensive. After 4 weeks, the overall best tissue response was with Kalzinol, followed closely by Vitrebond. The differences between materials for both time periods with either none or few inflammatory cells when compared with that with either moderate or severe inflammation were statistically significant (P < 0.01). Similarly, the differences between materials for both time periods with no inflammation or inflammation extending < 0.2 mm when compared with that with inflammation extending > 0.2 mm (< or = 0.5 mm or > 0.5 mm) were statistically significant (P < 0.01). Both Vitrebond and Kalzinol have potential as root-end filling materials as the tissue response was considerably more favourable than that to amalgam.
Radiopacity of potential root-end filling materials.
OBJECTIVES: In recent years various root-end filling materials have been suggested for clinical use. The purpose of this study was to assess the radiopacity of some potential materials according to ISO specification 6876. STUDY DESIGN: Radiographs were taken of 1-mm thick specimens of eight materials (amalgam, Kalzinol, IRM, Super EBA, Vitrebond, Fuji II LC, Chemfil, gutta-percha); light transmission was assessed densitometrically and related to equivalent thickness of aluminum. RESULTS: Commercial glass ionomer cements (Vitrebond, Fuji II LC, Chemfil) had radiopacities below the international standard for root canal sealers (< 3-mm aluminum); three zinc oxide-eugenol cements (Kalzinol, Super EBA, IRM) had radiopacities equivalent to 5 to 8 mm aluminum; and gutta-percha had a radiopacity equivalent to 6.1-mm aluminum. CONCLUSIONS: We recommend that root-end filling materials should have a radiopacity greater than that for root canal sealers.
Radiopacity of resin-modified glass-ionomer restorative cements.
This in vitro study compared the relative radiopacities of three commercially available resin-modified glass-ionomer cements (Vitremer, Fuji II LC, and Photac-Fil), an experimental resin-modified glass-ionomer (V-66), two conventional glass-ionomers (ChemFil and Fuji Cap II), and amalgam (as the control). Radiopacity was assessed densitometrically and expressed as equivalent thicknesses of aluminum. All the glass-ionomer cements were more radiopaque than enamel and dentin, with the exception of ChemFil and Photac-Fil. Apart from the control material, the experimental resin-modified glass-ionomer material, V-66, had the highest radiopacity of all the materials tested. Of the three resin-modified glass-ionomer materials tested, Fuji II LC was the most radiopaque and Photac-Fil the least. For the radiopacity of restorative glass-ionomer materials to exceed that of enamel, it should be greater than 1.5 mm of equivalent thickness of aluminum.
Endodontic retreatment. 2: Methods.
The best method for retreating a tooth that has already undergone root treatment will depend on the root filling technique and material used; a combination of retreatment techniques may be required. The correct method, combined with the required equipment, skill and experience, are necessary to produce a high standard of retreatment and a successful result. In part 1 of this article, the indications and case selection for root canal retreatment were discussed; this article will now discuss the methods of retreatment available.
Endodontic retreatment. 1: Indications and case selection.
Conventional root canal treatment, despite having a reportedly high success rate may not invariably lead to the desired healing response in clinical practice because of shortcomings in the treatment. This is the first of two articles on this subject, and will cover indications and case selection for root canal retreatment. Part 2 will discuss methods of retreatment.
Coronal leakage and treatment failure.
This report presents a case in which undiagnosed coronal leakage resulted in failure in the endodontic management of a tooth. Coronal leakage occurred during root canal treatment as a result of the presence of deficient composite resin fillings and secondary caries. Despite repeated visits of cleaning and dressing, the canal continued to be contaminated and symptoms persisted. On referral, the reason for treatment failure was diagnosed. The tooth was successfully treated by the replacement of the deficient fillings, after the elimination of underlying caries. Symptoms resolved enabling the completion of the root canal treatment.
Sealing ability of potential retrograde root filling materials.
The sealing ability of two potential retrograde root filling materials, a light-cured glass ionomer cement (Vitrebond) and a reinforced zinc oxide-eugenol cement (Kalzinol) was compared with that of amalgam using three methods of assessment: bacterial leakage, confocal microscopy and Indian ink leakage. the root canals of 80 extracted human single-rooted teeth were prepared. All the teeth were apicected, retrograde cavities were prepared and then divided into four equal groups of 20 teeth. The teeth were sterilised by autoclaving and the retrograde cavities filled with the test materials. In the control group, retrograde cavities in 10 teeth were left unfilled while cavities in another 10 teeth were sealed with cyanoacrylate cement. The teeth were first subjected to a bacterial leakage test using Enterococcus faecalis as a leakage marker. After which, the adaptation of the retrograde root fillings was assessed using a confocal optical microscope. Finally, the teeth were processed for the Indian ink leakage test. Bacterial leakage occurred in more teeth filled with amalgam compared with both Vitrebond and Kalzinol (P<0.001), between which there were no differences. With confocal microscopy, the size of the marginal gap was largest with amalgam and smallest with Vitrebond; all differences were statistically significant (<0.001). Finally, there was more Indian ink penetration with amalgam compared with both Vitrebond and Kalzinol (P<0.001) but there were no differences between Vitrebond and Kalzinol. Although there were individual differences within samples, overall, the three methods of assessment produced similar results. The sealing ability of Vitrebond and Kalzinol was similar and both materials were better than amalgam.
Antibacterial activity of potential retrograde root filling materials.
The antibacterial activity of potential retrograde root filling materials was assessed using the agar diffusion inhibitory test. A light-cured glass ionomer cement (Vitrebond) and three reinforced zinc oxide-eugenol cements (Kalzinol, IRM & ethoxybenzoic acid [EBA] cement) were compared with amalgam, a commonly used retrograde root filling material. Forty standardized pellets of each material were produced. Fresh, and materials aged for 1 week in sterile distilled water, were placed on blood agar plates inoculated with Streptococcus anginosus (milleri) or Enterococcus faecalis. At intervals of 3, 7 and 10 days, the presence and diameter of zones of inhibition were recorded. The diameter of the zones of inhibition increased with time for all materials, both fresh and aged. Vitrebond had the most pronounced antibacterial activity against both bacteria, producing the largest zone of inhibition, followed by Kalzinol. Amalgam had no measurable inhibitory effect whether aged or fresh, regardless of the period of exposure. There was no statistically significant difference in the response of the two bacteria. However, there were statistically significant differences between materials, period of exposure, and between fresh and aged materials (P < 0.001). Kalzinol, IRM and EBA cement were more antibacterial when aged than fresh, whilst Vitrebond was more active when fresh. Vitrebond was the only material for which the diameter of the zones of inhibition was reduced after ageing but it had the most pronounced antibacterial activity compared with the other materials. The antibacterial activity of the materials was ranked in the following order: Vitrebond > Kalzinol > (IRM = EBA cement) > amalgam.
Biological properties of IRM with the addition of hydroxyapatite as a retrograde root filling material.
The effect of adding 10% & 20% hydroxyapatite (HAP) on the antibacterial activity and cytotoxicity of IRM (Intermediate Restorative Material) when used as a retrograde root filling was compared with amalgam, a commonly used material. The antibacterial activity was assessed using the agar diffusion inhibitory test. Forty standardized pellets of each material were produced. Fresh materials, and materials aged for 1 week in sterile distilled water, were placed on blood agar plates inoculated with Streptococcus anginosus (milleri) or Enterococcus faecalis. The presence and diameter of zones of inhibition were recorded at intervals of 3, 7 and 10 days. There was no statistically significant overall difference in the response of the two bacteria tested. However, there were statistically significant overall differences in diameters of the zones of inhibition related to different materials, period of exposure and ageing of materials (P < 0.001). The diameter of the zones of inhibition increased with time for all materials, fresh and aged. IRM and both the HAP-modified forms produced large zones of inhibition. Amalgam produced no measureable zones of inhibition whether aged or fresh, regardless of period of exposure and was different from the other materials (P < 0.001). The cytotoxicity was assessed using the Millipore filter method. Ten standardized pellets of each material were produced and aged by storage in sterile distilled water for 72 h. Ten filters were included as controls. Amalgam produced a consistent cytotoxic score of 1, and the difference between amalgam and the other materials was statistically significant (P < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)